Skip to Main Content

Paper Details

Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.
Cancer Cell
86
2020
Author NameAffiliation
Tori N YamamotoNational Cancer Institute, National Institutes of Health (NIH), USA Center for Cell-based Therapy, Center for Cancer Research, University of Pennsylvania
Zhiya YuNational Cancer Institute, National Institutes of Health (NIH), USA Center for Cell-based Therapy, Center for Cancer Research
Zhiya YuNational Cancer Institute, National Institutes of Health (NIH), USA Center for Cell-based Therapy, Center for Cancer Research
Nicholas P RestifoNational Cancer Institute, National Institutes of Health (NIH), USA Center for Cell-based Therapy, Center for Cancer Research, University of Pennsylvania
Nicholas P RestifoNational Cancer Institute, National Institutes of Health (NIH), USA Center for Cell-based Therapy, Center for Cancer Research, University of Pennsylvania
  • 1 - 5

Datasets

Release 1.2